tiprankstipranks
Capricor Therapeutics (CAPR)
NASDAQ:CAPR
US Market
CAPR
Capricor Therapeutics
RESEARCH TOOLSreports
Want to see CAPR full AI Analyst Report?

Capricor Therapeutics (CAPR) Stock News & Sentiment

1,301 Followers
Capricor Faces Revenue Risk as Dependence on Nippon Shinyaku Puts Deramiocel Commercialization in Jeopardy
Premium
Company Announcements
Capricor Faces Revenue Risk as Dependence on Nippon Shinyaku Puts Deramiocel Commercialization in Jeopardy
2d ago
CAPR
Analyst Reiterates Buy on Capricor Ahead of Key 2026 PDUFA, Maintains $60 Price Target
Premium
Ratings
Analyst Reiterates Buy on Capricor Ahead of Key 2026 PDUFA, Maintains $60 Price Target
4d ago
CAPR
Capricor Buy Rating Reiterated on Deramiocel Opportunity and NS Pharma Dispute Dynamics; $50 Price Target Maintained
Premium
Ratings
Capricor Buy Rating Reiterated on Deramiocel Opportunity and NS Pharma Dispute Dynamics; $50 Price Target Maintained
5d ago
CAPR
Capricor Sues NS Pharma Over Deramiocel U.S. Rights
Premium
Company Announcements
Capricor Sues NS Pharma Over Deramiocel U.S. Rights
10d ago
8K
CAPR
3 ‘Perfect 10’ Smart Score Stocks to Buy this Week, 3/30/26, According to Analysts
Premium
Market News
3 ‘Perfect 10’ Smart Score Stocks to Buy this Week, 3/30/26, According to Analysts
2M ago
XEL
CAPR
Capricor Therapeutics Nears Key Milestones After Earnings Call
Premium
Company Announcements
Capricor Therapeutics Nears Key Milestones After Earnings Call
2M ago
CAPR
Deramiocel’s De‑Risked Path to Approval and Expanded DMD Opportunity Underpin Buy on CAPR
Premium
Ratings
Deramiocel’s De‑Risked Path to Approval and Expanded DMD Opportunity Underpin Buy on CAPR
2M ago
CAPR
More CAPR News >

CAPR News on the Web

Capricor Faces Revenue Risk as Dependence on Nippon Shinyaku Puts Deramiocel Commercialization in Jeopardy
TipRanks News
Bearish
Capricor Therapeutics price target lowered to $38 from $43 at Roth Capital
TipRanks News
Bearish
Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
CAPR SWOT Analysis: Financial Challenges and Growth Potential Revealed in 10-Q Filing
GuruFocus News
Neutral
Cantor Fitzgerald Reaffirms Their Buy Rating on Capricor Therapeutics (CAPR)
TipRanks News
Bullish
Analysts Are Bullish on These Healthcare Stocks: AnaptysBio (ANAB), Legend Biotech (LEGN)
TipRanks News
Neutral
Analyst Reiterates Buy on Capricor Ahead of Key 2026 PDUFA, Maintains $60 Price Target
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
CAPR
Sector Average
Media Buzz
This Week16 articles
Weekly Average2 articles
News Sentiment
This Week82%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CAPR’s Media Buzz Sentiment?
16 articles about CAPR were published this week. In an average week, 2 articles are published.
    What is CAPR’s weekly average amount of articles?
    In an average week, 2 articles about CAPR are published.
      What is CAPR’s News Sentiment?
      82% of articles about CAPR were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week